CorMedix Inc. (CRMD) Research

CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.

Market snapshot

Symbol
CRMD
Price
$8.67
Day change
0.00%
Market cap
$680.2M
P/E ratio
3.81x
52-week range
6.13-17.43
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$14.00

Recent news

  • CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

    CorMedix Therapeutics Inc. (NASDAQ:CRMD) raised its full-year 2026 revenue and adjusted EBITDA guidance after reporting strong first-quarter results driven by higher utilization of DefenCath and contributions from the acquired Melinta portfolio.

  • CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study

    CorMedix Inc. (NASDAQ:CRMD) shares are up on Monday following the announcement of positive topline results from the Phase 3 ReSPECT trial assessing REZZAYO (rezafungin) for the prophylaxis of invasive fungal diseases in adult patients undergoing allogeneic blood and marrow transplant.

Peer companies

  • Arbutus Biopharma Corporation (ABUS)
  • Bicara Therapeutics Inc. Common Stock (BCAX)
  • EyePoint Pharmaceuticals, Inc. (EYPT)
  • Kura Oncology, Inc. (KURA)
  • Nanobiotix S.A. (NBTX)
  • ProKidney Corp. (PROK)
  • Palvella Therapeutics, Inc. (PVLA)
  • Septerna, Inc. (SEPN)

Recent insider activity

  • Zelnick Kaufman Beth — A-Award (36006 shares) on 2026-02-04
  • Hurlburt Elizabeth — A-Award (36006 shares) on 2026-02-04
  • Todisco Joseph — A-Award (77156 shares) on 2026-02-04
  • Blum Susan — A-Award (72820 shares) on 2026-01-23
  • Blum Susan — F-InKind (9767 shares) on 2026-01-23

Open CorMedix Inc. (CRMD) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.